Pharmaust Limited (AU:PAA) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
PharmAust Limited reports a 9% decrease in revenues and a 24% increase in losses for the fiscal year ending June 30, 2024, compared to the previous year, with no dividends paid. The company’s net assets have shown a significant increase, rising to $10,228,243 from $3,889,135, while experiencing a loss of control over subsidiaries Epichem Pty Ltd and Epichem OHD Pty Ltd. The full annual report has been audited and is attached to the release.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.
